Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

Rapid reduction of glucocorticoid (GC) doses to 7.5 mg/day or less within 6 months may not worsen renal outcomes or increase relapse in patients with proliferative lupus nephritis (LN), recent study ...

Medical AI tools for clinicians and patients have advantages and disadvantages, including implicit bias in triage and virtual urgent care.

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

Only incidence and prevalence rates attributable to keratinocyte cancer, DALYs attributable to BCC would increase by 2050 ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes.

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

Belimumab, a monoclonal antibody, added to standard therapy may treat a broader range of patients with lupus nephritis than previously appreciated.

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

Disability prevalence 14.1 percent for current smokers, 6.8 percent for never smokers, and 12.6 percent for former smokers.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.